Genetic and structural characterization of dengue virus involved in the 2023 autochthonous outbreaks in central Italy.

arbovirus dengue genomic surveillance molecular epidemiology whole-genome sequencing

Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
30 Oct 2024
Historique:
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: aheadofprint

Résumé

Dengue virus (DENV) has been expanding its range to temperate areas that are not usually affected, where the spread of vectors has been facilitated by global trade and climate change. In Europe, there have been many cases of DENV imported from other regions in the past few years, leading to local outbreaks of DENV among people without travel history. Here we describe the epidemiological and molecular investigations of three transmission events locally acquired DENV infections caused by serotypes 1, 2, and 3, respectively, in the Latium Region from August to November 2023. Next-generation or Sanger sequencing were used to obtain the whole genomes, or the complete E-gene of the viruses, respectively. The structure of the DENV-1 and DENV-3 sequences was analysed to identify amino acid changes that were not found in the closest related sequences. The major cluster was supported by DENV-1 (originated in South America), with 42 autochthonous infections almost occurring in the eastern area of Rome, probably due to a single introduction followed by local sustained transmission. Seven DENV-1 subclusters have been identified by mutational and phylogenetic analysis. Structural analysis indicated changes whose meaning can be explained by the adaptation of the virus to human hosts and vectors and their interactions with antibodies and cell receptors.

Identifiants

pubmed: 39475407
doi: 10.1080/22221751.2024.2420734
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2420734

Auteurs

Fabrizio Carletti (F)

Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Gabriella De Carli (G)

Regional Service for Surveillance and Control of Infectious Diseases (SeRESMI)-Lazio Region, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Pietro Giorgio Spezia (PG)

Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Cesare Ernesto Maria Gruber (CE)

Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Ingrid Guarnetti Prandi (IG)

Dipartimento per l'Innovazione nei sistemi Biologici, Agroalimentari e Forestali (DIBAF), Università degli Studi della Tuscia, Viterbo, Italy.

Martina Rueca (M)

Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Alessandro Agresta (A)

Regional Service for Surveillance and Control of Infectious Diseases (SeRESMI)-Lazio Region, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Eliana Specchiarello (E)

Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Lavinia Fabeni (L)

Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Elisa San Giovanni (ES)

Dipartimento per l'Innovazione nei sistemi Biologici, Agroalimentari e Forestali (DIBAF), Università degli Studi della Tuscia, Viterbo, Italy.

Chiara Arcuri (C)

Dipartimento per l'Innovazione nei sistemi Biologici, Agroalimentari e Forestali (DIBAF), Università degli Studi della Tuscia, Viterbo, Italy.

Martina Spaziante (M)

Regional Service for Surveillance and Control of Infectious Diseases (SeRESMI)-Lazio Region, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Daniele Focosi (D)

North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.

Paola Scognamiglio (P)

Regional Service for Surveillance and Control of Infectious Diseases (SeRESMI)-Lazio Region, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
Directorate for Health and Social Policy, Lazio Region, Rome, Italy.

Alessandra Barca (A)

Directorate for Health and Social Policy, Lazio Region, Rome, Italy.

Emanuele Nicastri (E)

Clinical and Research Department, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.

Enrico Girardi (E)

Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.

Giovanni Chillemi (G)

Dipartimento per l'Innovazione nei sistemi Biologici, Agroalimentari e Forestali (DIBAF), Università degli Studi della Tuscia, Viterbo, Italy.
Institute of Translational Pharmacology, National Research Council, CNR, 00133 Rome, Italy.

Francesco Vairo (F)

Regional Service for Surveillance and Control of Infectious Diseases (SeRESMI)-Lazio Region, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Fabrizio Maggi (F)

Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

Classifications MeSH